The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Potentially avoidable acute care use among patients receiving oxaliplatin.
 
Eric Roeland
Honoraria - Pfizer
Consulting or Advisory Role - AIM Specialty Health; BASF; Helsinn Healthcare (Inst); Napo Pharmaceuticals; Oragenics; Pronova (Inst)
 
Thomas William LeBlanc
Honoraria - Celgene; Helsinn Therapeutics; Quintiles
Consulting or Advisory Role - Amgen; Flatiron Health; Helsinn Therapeutics; Heron; Otsuka; Pfizer; Seagen
Research Funding - AstraZeneca (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Heron; Otsuka
 
Kathryn Jean Ruddy
Stock and Other Ownership Interests - Merck; Pfizer
Patents, Royalties, Other Intellectual Property - My husband is a co-inventor of technology licensed by Mayo Clinic to AliveCor (MountainView, CA), which makes a smartphone-enabled remote ECG monitoring system. (I)
 
Rebecca Anne Clark-Snow
Honoraria - Merck; Tesaro
Consulting or Advisory Role - Merck; Tesaro
Speakers' Bureau - Merck
 
Gary Binder
Employment - Helsinn Therapeutics
Stock and Other Ownership Interests - Celgene
 
William L. Bailey
Employment - Helsinn Therapeutics
Stock and Other Ownership Interests - Pfizer
 
Ravi C. Potluri
Other Relationship - Helsinn, BMS, Janssen
 
Luke M. Schmerold
Employment - SmartAnalyst
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Helsinn Healthcare (Inst); Janssen (Inst); LEO Pharma (Inst)
 
Eros Papademetriou
Stock and Other Ownership Interests - Express Scripts
Honoraria - Otsuka (I)
Research Funding - Abbvie (Inst); Helsinn Therapeutics (Inst); Janssen (Inst); LEO Pharma (Inst)
 
Rudolph M. Navari
No Relationships to Disclose